PAVmed (PAVM) Return on Capital Employed (2016 - 2026)
PAVmed (PAVM) posted quarterly Return on Capital Employed of 92.39% for Q4 2025, down 74146.0% year-over-year from N/an in Q4 2024, and down 39.66% quarter-over-quarter from 66.16% in Q3 2025.
PAVmed (PAVM) Return on Capital Employed (2016 - 2026) Analysis & Trends
PAVmed's Return on Capital Employed history runs 10 years deep, the most recent figure standing at 92.39% for Q4 2025.
- In Q4 2025, Return on Capital Employed fell 74146.0% year-over-year to 92.39%; the TTM figure through Dec 2025 stood at 92.39% (down 74146.0% YoY), while the FY2025 annual figure was 109.58%, down 136045.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 92.39%, down from 66.16% in the prior quarter.
- The five-year high for Return on Capital Employed was 1157.5% in Q3 2023, with the low at 1010.82% in Q1 2023.
- The 5-year median for Return on Capital Employed is 93.56% (2025), against an average of 26.81%.
- Peak annual rise in Return on Capital Employed reached 139988 bps in 2023, while the deepest fall reached 91406 bps in 2023.
- PAVmed's Return on Capital Employed stood at 94.73% in 2021, then tumbled by 337 bps to 413.61% in 2022, then soared by 200 bps to 414.25% in 2023, then surged by 57 bps to 649.07% in 2024, then slumped by 114 bps to 92.39% in 2025.
- Business Quant data shows PAVM's Return on Capital Employed at 92.39% in Q4 2025, 66.16% in Q3 2025, and 76.7% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | PAVmed | 32.48 Mn | 28.69 Mn | -89,000.00 | -66.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -66.01% |
| Dec 31, 2025 | -92.39% |
| Sep 30, 2025 | -66.16% |
| Jun 30, 2025 | -76.70% |
| Mar 31, 2025 | -120.00% |
| Dec 31, 2024 | 649.07% |
| Jun 30, 2024 | 396.05% |
| Mar 31, 2024 | 314.85% |
| Dec 31, 2023 | 414.25% |
| Sep 30, 2023 | 1,157.50% |
| Jun 30, 2023 | -975.38% |
| Mar 31, 2023 | -1,010.82% |
| Dec 31, 2022 | -413.61% |
| Sep 30, 2022 | -242.39% |
| Jun 30, 2022 | -171.73% |
| Mar 31, 2022 | -96.76% |
| Dec 31, 2021 | -94.73% |
| Sep 30, 2020 | 131.74% |
| Jun 30, 2020 | 150.34% |
| Dec 31, 2019 | 236.08% |